Cargando…
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
PURPOSE: Laser ablation of the avascular peripheral retina has been the standard method of ROP treatment. Intravitreal anti-VEGF is useful in the management of ROP patients, especially for aggressive posterior ROP. However, ocular and systemic complication after intravitreal bevacizumab was the main...
Autores principales: | Bazvand, Fatemeh, Riazi-Esfahani, Hamid, Mirshahi, Ahmad, Khodabande, Alireza, Khojastheh, Hasan, Farahani, Afsar Dastjani, Roohipourmoallai, Ramak, Imani, Marjan, Faghihi, Hooshang, Adib, Nazanin Ebrahimi, Bahar, Mohammadreza Mehrabi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802148/ https://www.ncbi.nlm.nih.gov/pubmed/33431069 http://dx.doi.org/10.1186/s40942-020-00276-3 |
Ejemplares similares
-
Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
por: Mirshahi, Ahmad, et al.
Publicado: (2021) -
Prevalence and Risk Factors of Retinopathy of Prematurity in Iran
por: Zarei, Mohammad, et al.
Publicado: (2019) -
The Accuracy of Digital Imaging in Diagnosis of Retinopathy of Prematurity in Iran: A Pilot Study
por: Karkhaneh, Reza, et al.
Publicado: (2019) -
Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2022) -
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
por: Riazi-esfahani, Hamid, et al.
Publicado: (2021)